Mackay Shields’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
NICM
RG
Mackay Shields's ALXN Position: Q3 2021 in Review
Mackay Shields sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 34,871 shares — an estimated $6.41M sold.
Mackay Shields first reported a position in ALXN in Q1 2018 and held it in 13 quarters. The position peaked at $23.6M in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.
- Mackay Shields reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Mackay Shields sold 34,871 Alexion Pharmaceuticals shares in Q3 2021, an estimated $6.41M.
- Mackay Shields first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 13 quarters.
- Mackay Shields's Alexion Pharmaceuticals position peaked at $23.6M in Q3 2020.
- 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.
Based on Mackay Shields's 13F filing for Q3 2021, filed 12 Nov 2021.